Therapeutic Potential of Pluripotent Human Embryonic and Reprogrammed Somatic Stem Cells
Epigenetics
Commercialisation of Stem Cell Research
Start-Up Case Studies
Regulatory and IP Situation
Bioethics Related to Stem Cells
Funding Sources for Stem Cell Research
Confirmed Speakers: Geoff RaismanProfessor, University College London Karim NayerniaProfessor, Newcastle University Andrei Novik Professor, National Medical Surgical Center Russia Enal Razvi Biotech Analyst, Select Biosciences Alain Chapel Senior Investigator in Cell Therapy, Institute of Nuclear Safety Eva Sykova Director of Institute, Institute of Experimental Medicine ASCR Michael Detamore Associate Professor, University of Kansas Jianhong Zhu Professor, Fudan University Huashan Hospital Michael Edel Carlos III Principle Investigator, Center of Regenerative Medicine Carlo Ventura Professor, University of Bologna Joyce Frey-Caconcells Director, PharmaNet Development Group Jaspal Khillan Associate Professor, University of Pittsburgh Bernard Binetruy Researcher, Inserm Donna McLaren Head of Development and Production, Stem Cell Sciences UK Mie Cong R&D Research Manager, Promega Philippa Montgomerie Partner, DLA Piper Marilyn Robertson Director of Operations, Scottish Stem Cells Network